Van Oene Mark bought PACB
August 10, 2026 · Form 4 insider transaction
Van Oene Mark bought 489,130 shares of Pacific Biosciences of California, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
489,130
Price
$0.00
Total value
N/A
InsiderVan Oene Mark
Role—
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateAugust 10, 2026
Filing dateAugust 11, 2026
Shares owned after2,732,764
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each share is represented by a Restricted Stock Unit ("RSU"). The RSUs will vest in equal annual installments on August 10 of each of 2027, 2028, and 2029, subject to the Reporting Person's continued status as a service provider through the applicable vesting dates.